Revocation of European patent for neural progenitors highlights patent challenges for inventions relating to human embryonic stem cells
{{output}}
Cells derived from human embryonic stem cells have great therapeutic potential. Patents are key to allowing companies that develop methods of generating such cells to recuperate their investment. However, in Europe, inventions relating to the use of human embr... ...